Please assess the completion status of the following clinical trial:

Trial Title: MultiPoint Pacing IDE Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets current clinical indication for implantation of a cardiac resynchronization therapy system for treatment of heart failure or life-threatening ventricular tachyarrhythmia(s)~* Receiving a new CRT implant or undergoing an upgrade from an existing ICD or pacemaker implant with no prior LV lead placement~* Have the ability to provide informed consent for study participation and are willing and able to comply with the prescribed follow-up tests and schedule of evaluations~Exclusion Criteria:~* Have had a recent Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) within 3 months of enrollment~* Have an existing Class I recalled lead~* Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate~* Have a classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 9 months~* Have permanent atrial fibrillation (AF)~* Have undergone a cardiac transplantation within 40 days of enrollment~* Have had a recent myocardial infarction, unstable angina within 40 days or cardiac revascularization within 3 months of implant.~* Are currently participating in a clinical investigation that includes an active treatment arm~* Are pregnant or planning to become pregnant during the duration of the study~* Have a life expectancy of less than 9 months due to any condition~* Are less than 18 years of age

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multi-point pacing arm (Type: EXPERIMENTAL): MultiPoint Pacing
- Biventricular arm (Type: ACTIVE_COMPARATOR): Traditional Biventricular Pacing

Based on this trial design, predict the completion outcome and termination type (if applicable).